Genetic and immune landscape evolution in MMR-deficient colorectal cancer.

Autor: Challoner BR; The Institute of Cancer Research, London, UK., Woolston A; Barts Cancer Institute, Queen Mary University of London, London, UK., Lau D; The Royal Marsden NHS Foundation Trust, London, UK., Buzzetti M; Barts Cancer Institute, Queen Mary University of London, London, UK., Fong C; The Royal Marsden NHS Foundation Trust, London, UK., Barber LJ; Barts Cancer Institute, Queen Mary University of London, London, UK., Anandappa G; The Royal Marsden NHS Foundation Trust, London, UK., Crux R; The Royal Marsden NHS Foundation Trust, London, UK., Assiotis I; The Institute of Cancer Research, London, UK., Fenwick K; The Institute of Cancer Research, London, UK., Begum R; The Royal Marsden NHS Foundation Trust, London, UK., Begum D; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Lund T; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Sivamanoharan N; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Sansano HB; The Royal Marsden NHS Foundation Trust, London, UK., Domingo-Arada M; The Royal Marsden NHS Foundation Trust, London, UK., Tran A; The Royal Marsden NHS Foundation Trust, London, UK., Pandha H; University of Surrey, Guildford, UK., Church D; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Eccles B; University Hospitals Dorset NHS Foundation Trust, Bournemouth, UK., Ellis R; Royal Cornwall Hospitals NHS Trust, Truro, UK., Falk S; University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Hill M; Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK., Krell D; Royal Free London NHS Foundation Trust, London, UK., Murugaesu N; St George's University Hospitals NHS Foundation Trust, London, UK.; Genomics England, London, UK., Nolan L; Hampshire Hospitals NHS Foundation Trust, Winchester, UK., Potter V; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK., Saunders M; The Christie NHS Foundation Trust, Manchester, UK., Shiu KK; University College London Hospitals NHS Foundation Trust, London, UK., Guettler S; The Institute of Cancer Research, London, UK., Alexander JL; Imperial College Healthcare NHS Trust, London, UK., Lázare-Iglesias H; University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain., Kinross J; Imperial College Healthcare NHS Trust, London, UK., Murphy J; Imperial College Healthcare NHS Trust, London, UK., von Loga K; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Cunningham D; The Royal Marsden NHS Foundation Trust, London, UK., Chau I; The Royal Marsden NHS Foundation Trust, London, UK., Starling N; The Royal Marsden NHS Foundation Trust, London, UK., Ruiz-Bañobre J; University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain.; University of Santiago de Compostela, Santiago de Compostela, Spain., Dhillon T; Royal Surrey Hospital NHS Foundation Trust, Guildford, UK., Gerlinger M; Barts Cancer Institute, Queen Mary University of London, London, UK.; St Bartholomew's Hospital Cancer Centre, London, UK.

Publikováno v: The Journal of pathology [J Pathol] 2024 Feb; Vol. 262 (2), pp. 226-239. Date of Electronic Publication: 2023 Nov 15.

Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy.

Autor: Pérez-Martelo M; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, Spain.; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain., González-García A; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain., Vidal-Ínsua Y; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, Spain.; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain., Blanco-Freire C; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, Spain.; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain., Brozos-Vázquez EM; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, Spain.; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain., Abdulkader-Nallib I; Pathology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain., Álvarez-Fernández J; Medical Oncology Department, Lucus Augusti University Hospital, 27003, Lugo, Spain., Lázare-Iglesias H; Pathology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain., García-Martínez C; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, Spain.; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain., Betancor YZ; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain.; Genomes and Disease, Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain., Sánchez-Ares M; Pathology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain., Tubío JMC; Genomes and Disease, Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain., Vázquez-Rivera F; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, Spain.; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain., Candamio-Folgar S; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, Spain.; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain., López-López R; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, Spain. rafael.lopez.lopez@sergas.es.; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain. rafael.lopez.lopez@sergas.es.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain. rafael.lopez.lopez@sergas.es., Ruiz-Bañobre J; Medical Oncology Department, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Travesía da Choupana S/N, 15706, Santiago de Compostela, Spain. juan.ruiz.banobre@sergas.es.; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain. juan.ruiz.banobre@sergas.es.; Genomes and Disease, Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), 15706, Santiago de Compostela, Spain. juan.ruiz.banobre@sergas.es.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain. juan.ruiz.banobre@sergas.es.

Publikováno v: Scientific reports [Sci Rep] 2022 Apr 27; Vol. 12 (1), pp. 6893. Date of Electronic Publication: 2022 Apr 27.

Histological diagnosis of solid pancreatic lesions from a prospective endoscopic ultrasound-based registry: All that seems is not ductal adenocarcinoma

Autor: Iglesias-Garcia, J., De La Iglesia-Garcia, D., Lariño-Noia, J., Abdulkader-Nallib, I., Lazare-Iglesias, H., Dominguez-Muñoz, J.E.

Publikováno v: In Pancreatology July 2021 21 Supplement 1:S81-S81

3D Printed Tacrolimus Rectal Formulations Ameliorate Colitis in an Experimental Animal Model of Inflammatory Bowel Disease.

Autor: Seoane-Viaño I; Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain.; Paraquasil Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain., Gómez-Lado N; Nuclear Medicine Department and Molecular Imaging Group, University Clinical Hospital (CHUS) and Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain., Lázare-Iglesias H; Pathology Department, University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), 15706 Santiago de Compostela, Spain., García-Otero X; Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain.; Nuclear Medicine Department and Molecular Imaging Group, University Clinical Hospital (CHUS) and Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain., Antúnez-López JR; Pathology Department, University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), 15706 Santiago de Compostela, Spain., Ruibal Á; Nuclear Medicine Department and Molecular Imaging Group, University Clinical Hospital (CHUS) and Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.; Tejerina Foundation, José Abascal 40, 28003 Madrid, Spain., Varela-Correa JJ; Pharmacy Department, University Hospital Ourense (SERGAS), Calle Ramón Puga Noguerol 54, 32005 Ourense, Spain., Aguiar P; Nuclear Medicine Department and Molecular Imaging Group, University Clinical Hospital (CHUS) and Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain., Basit AW; FabRx Ltd., 3 Romney Road, Ashford, Kent TN24 0RW, UK.; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK., Otero-Espinar FJ; Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain.; Paraquasil Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain., González-Barcia M; Pharmacy Department, University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), 15706 Santiago de Compostela, Spain., Goyanes A; FabRx Ltd., 3 Romney Road, Ashford, Kent TN24 0RW, UK.; Department of Pharmaceutics, UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma Group (GI-1645), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain., Luzardo-Álvarez A; Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela (USC), 15782 Santiago de Compostela, Spain.; Paraquasil Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain., Fernández-Ferreiro A; Pharmacy Department, University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), 15706 Santiago de Compostela, Spain.; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.

Publikováno v: Biomedicines [Biomedicines] 2020 Dec 02; Vol. 8 (12). Date of Electronic Publication: 2020 Dec 02.

Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model.

Autor: Seoane-Viaño I; Pharmacy and Pharmaceutical Technology Department and Industrial Pharmacy Institute, Faculty of Pharmacy, Universidade de Santiago de Compostela (USC), Campus Vida, Santiago de Compostela 15782, Spain., Gómez-Lado N; Molecular Imaging Group, Department of Psiquiatry, Radiology and Public Health, Faculty of Medicine, Universidade de Santiago de Compostela (USC), Santiago de Compostela 15782, Spain; Molecular Imaging Group, Health Research Institute of Santiago de Compostela (IDIS), Travesía da Choupana s/n, Santiago de Compostela 15706, Spain., Lázare-Iglesias H; Pathology Department, University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Barreiro-de Acosta M; Gastroenterology Department, University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Silva-Rodríguez J; Molecular Imaging Group, Department of Psiquiatry, Radiology and Public Health, Faculty of Medicine, Universidade de Santiago de Compostela (USC), Santiago de Compostela 15782, Spain; Molecular Imaging Group, Health Research Institute of Santiago de Compostela (IDIS), Travesía da Choupana s/n, Santiago de Compostela 15706, Spain., Luzardo-Álvarez A; Pharmacy and Pharmaceutical Technology Department and Industrial Pharmacy Institute, Faculty of Pharmacy, Universidade de Santiago de Compostela (USC), Campus Vida, Santiago de Compostela 15782, Spain., Herranz M; Molecular Imaging Group, Health Research Institute of Santiago de Compostela (IDIS), Travesía da Choupana s/n, Santiago de Compostela 15706, Spain., Otero-Espinar F; Pharmacy and Pharmaceutical Technology Department and Industrial Pharmacy Institute, Faculty of Pharmacy, Universidade de Santiago de Compostela (USC), Campus Vida, Santiago de Compostela 15782, Spain., Antúnez-López JR; Pathology Department, University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Lamas MJ; Pharmacy Department, University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), Travesía Choupana s/n, Santiago de Compostela 15706, Spain; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), Travesía da Choupana s/n, Santiago de Compostela 15706, Spain., Aguiar P; Molecular Imaging Group, Department of Psiquiatry, Radiology and Public Health, Faculty of Medicine, Universidade de Santiago de Compostela (USC), Santiago de Compostela 15782, Spain; Molecular Imaging Group, Health Research Institute of Santiago de Compostela (IDIS), Travesía da Choupana s/n, Santiago de Compostela 15706, Spain; Nuclear Medicine Department, University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), Travesía Choupana s/n, Santiago de Compostela 15706, Spain., Fernández-Ferreiro A; Pharmacy Department, University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), Travesía Choupana s/n, Santiago de Compostela 15706, Spain; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), Travesía da Choupana s/n, Santiago de Compostela 15706, Spain. Electronic address: anxordes@gmail.com., Ruibal Á; Molecular Imaging Group, Department of Psiquiatry, Radiology and Public Health, Faculty of Medicine, Universidade de Santiago de Compostela (USC), Santiago de Compostela 15782, Spain; Molecular Imaging Group, Health Research Institute of Santiago de Compostela (IDIS), Travesía da Choupana s/n, Santiago de Compostela 15706, Spain; Nuclear Medicine Department, University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), Travesía Choupana s/n, Santiago de Compostela 15706, Spain; Tejerina Foundation, José Abascal 40, Madrid 28003, Spain. Electronic address: alvaro.ruibal.morell@sergas.es.

Publikováno v: International journal of pharmaceutics [Int J Pharm] 2018 Oct 05; Vol. 549 (1-2), pp. 335-342. Date of Electronic Publication: 2018 Aug 03.